ArticleJournal of molecular medicine (Berlin, Germany)2025
Glis3 as a critical regulator of Pit1-lineages and renal functions.
Article in Journal of molecular medicine (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Krüppel-like GLIS3 transcription factor acts as an effector on the sonic hedgehog (Shh) pathway, regulating several biological processes and the development and postnatal function of various tissues. Given the major role of Shh signaling during the differentiation and anterior/posterior patterning of the adenohypophysis (AH) anlage, we investigated the potential role of glis3 during AH development in the zebrafish model. Glis3KD embryos exhibited increased expression of early AH-inductive genes lim3 and nkx2.2a, along with an expansion of pit1-positive precursors. This shift led to an overproduction of lactotropes, somatolactotropes, and thyrotropes, at the expense of somatotropes, corticotropes, and melanotropes. The most striking difference is the hyperprolactinemia observed in glis3KD larvae, with transcript and protein levels increased by approximately 30-fold and threefold, respectively, compared to controls. As a consequence of the primary role for prolactin in controlling fish osmoregulation, glis3KD larvae exhibited the upregulation of ionocytes expressed in gills and pronephric ducts. Furthermore, glis3KD larvae presented abnormal pronephric primary cilia and glomerular cysts in keeping with the established role of GLIS3 in ciliopathies and polycystic kidney disease. In conclusion, glis3 action appears fundamental to set an adequate number of pit1-precursors and renal function. KEY MESSAGES: Glis3 regulates pituitary cell fate by balancing pit1-positive precursors. Glis3 knockdown leads to hyperprolactinemia and altered osmoregulatory mechanisms. Glis3 is essential for normal cilia structure and pronephric kidney function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.